Furthermore, a derivative of the peptide CAP37 was recently shown to be effective in clearing P. aeruginosa corneal infection as well as in accelerating corneal wound healing in vivo, although the concentrations used for the antibacterial activity were significantly higher (in the range of mM) compared to those displaying wound healing activity (in the μM range) [57]. Here, AZU1 is linked to corneal infection.